Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability (V186-001)
Clinical trial NCT02996890 · COMPLETED
Trial details
- NCT number
- NCT02996890
- Sponsor
- Themis Bioscience GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-03
- Primary completion
- 2018-01-04
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.